All filters
Slidesets
Virological Efficacy of First-Line Regimens, Resistance Profile and Factors Influencing Adherence to ART in Clinical Practice in Ukraine - Tetiana Kyrychenko
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Switching to Second Line HIV Therapy - Pavel Khaykin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
PrEP and STI Testing in CEE: What are the Barriers, What Works? - Miłosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Epidemiology of HIV in the Baltic Countries (Estonia, Latvia, Lithuania) - Saulius Čaplinskas
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Integrated Testing for HIV, Hepatitis, and STIs - Dorthe Raben, MSc
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
The New Tendencies in HIV and HCV Epidemics in Central Region of Ukraine - Tetiana Koval
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Management of Hepatitis C in Primary Healthcare in the Country of Georgia - Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
HCV Prevalence and Associated Factors Among People who Inject Drugs (PWID): Baseline Results of Georgian PWID Cohort Study - Ketevan Shermadini
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Outcomes for Hepatitis B Vaccination Among HIV-Infected Adults in Georgia - Shorena Dvali
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Diversity of HIV-1 Subtypes in Russia 2009-2019 - Konstantin Gromov
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Epidemiology of Hepatitis B Viral Infection in the Republic of Belarus - Viktar Mitsura
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
High Level of Integrase Strand Transfer Inhibitors Drug Resistance Mutations in INSTIs Failed HIV-1 CRF06_cpx Infected Patients in Estonia - Merit Pauskar
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Implementation of the State Program on Elimination of Viral Hepatitis C in Ukraine: Achievements and Challenges - Kristyna Pronyuk
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Vaccinations for HIV Patients: Which Vaccinations When and How? - Carolynne Schwarze-Zander, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
HIV/HCV Co-Infection: Influence on Risk for Cancer and Cardiovascular Events, and Impact of Successful HCV Cure - Ligita Jancoriene, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Selected INSTI Highlights - CROI 2019 - Charles Boucher, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
The Impact of Antiretroviral Drug Resistance in Taiwanese HIV-1-Infected MSM Population Between 2015 and 2018 - Yen-Ju Chen
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-Tablet Antiretroviral Regimens - Kuan-Yeh Lee
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Clinical experience INSTI in Japan S- Shinichi Oka, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Clinical experience INSTI in Thailand - Kiat Ruxrungtham, MD
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in Bangkok - Donn Colby
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance? - Donn Colby
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Dolutegravir Plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV Post-Exposure Prophylaxis: Efficacy and Safety Results from Real World Study - Chongxi Li
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
INSTI Use in Women of Child-Bearing Age - NTD Toxicity - Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Presented at:
Asia-Pacific HIV Clinical Forum 2019